Related Experiment Videos
Amantadine, livedo reticularis, and antiphospholipid antibodies
Clinical Neuropharmacology
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alpha (activated).
Journal of thrombosis and haemostasis : JTH·2009
Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease.
Journal of clinical pharmacy and therapeutics·2009
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects.
Current medical research and opinion·2009
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.
Journal of thrombosis and haemostasis : JTH·2007
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.
Journal of thrombosis and haemostasis : JTH·2007
Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently.
Clinical pharmacology and therapeutics·2007
Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.
Clinical neuropharmacology·2026
Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.
Clinical neuropharmacology·2026
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Clinical neuropharmacology·2026
Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.
Clinical neuropharmacology·2026
Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.
Clinical neuropharmacology·2026
Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.
Journal of diabetes investigation·2026
Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.
Arthritis & rheumatology (Hoboken, N.J.)·2026